- Role
- Country
- Date of registration
- Address
NL-MF-000000437SALSA MLPA Probemix P002 BRCA1 is an EU IVDR-regulated in vitro diagnostic registered in EUDAMED. It is classified as IVDR Class C. Manufactured by MRC Holland B.V.. Placed on the EU market in Netherlands. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on Apr 1, 2026
872021148P00258Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
(01)08720211480010
The compliance carrier: encodes the device identifier plus the production identifiers (lot, serial, dates) registered for this device.
1 warning recorded — scroll inside the panel to see all entries.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Primary placement in Netherlands; available across 32 countries total.
| Country | On market since | Until |
|---|---|---|
| NetherlandsPrimary placement | Nov 4, 2024 | Still on market |
| Austria | Nov 4, 2024 | Still on market |
| Belgium | Nov 4, 2024 | Still on market |
| Bulgaria | Nov 4, 2024 | Still on market |
| Cyprus | Nov 4, 2024 | Still on market |
| Czechia | Nov 4, 2024 | Still on market |
| Germany | Nov 4, 2024 | Still on market |
| Denmark | Nov 4, 2024 | Still on market |
| Estonia | Nov 4, 2024 | Still on market |
| EL | Nov 4, 2024 | Still on market |
| Spain | Nov 4, 2024 | Still on market |
| Finland | Nov 4, 2024 | Still on market |
| France | Nov 4, 2024 | Still on market |
| Croatia | Nov 4, 2024 | Still on market |
| Hungary | Nov 4, 2024 | Still on market |
| Ireland | Nov 4, 2024 | Still on market |
| Iceland | Nov 4, 2024 | Still on market |
| Italy | Nov 4, 2024 | Still on market |
| Liechtenstein | Nov 4, 2024 | Still on market |
| Lithuania | Nov 4, 2024 | Still on market |
| Luxembourg | Nov 4, 2024 | Still on market |
| Latvia | Nov 4, 2024 | Still on market |
| Malta | Nov 4, 2024 | Still on market |
| Norway | Nov 4, 2024 | Still on market |
| Poland | Nov 4, 2024 | Still on market |
| Portugal | Nov 4, 2024 | Still on market |
| Romania | Nov 4, 2024 | Still on market |
| Sweden | Nov 4, 2024 | Still on market |
| Slovenia | Nov 4, 2024 | Still on market |
| Slovakia | Nov 4, 2024 | Still on market |
| Türkiye | Nov 4, 2024 | Still on market |
| XI | Nov 4, 2024 | Still on market |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
08720211480010Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
872021148P00258P002-100RUDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0106010199MONOGENETIC DISORDERS TESTS - OTHER872021148ME032ZHOn the marketSALSA MLPA Probemix P002 BRCA1872021148P00258On the marketSALSA MLPA Probemix P002 BRCA1872021148P00258On the marketSALSA MLPA Probemix P008 PMS2872021148P0085LOn the marketSALSA MLPA Probemix P008 PMS2872021148P0085LOn the marketSALSA MLPA Probemix P008 PMS2872021148P0085LOn the marketNo certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.No certificate specifically references this device's Basic UDI-DI.